A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS-CoV-2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls

Administered By

Awarded By

Contributors

Start/End

  • June 9, 2021 - March 31, 2023